Gene · 3020
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T-cell receptor sequencing. | Mol Oncol | 2023 | 36703611 | PubTator, text mining | PubMed |
| Spinal Metastasis in a Patient with Supratentorial Glioblastoma with Primitive Neuronal Component: A Case Report with Clinical and Molecular Evaluation. | Diagnostics (Basel) | 2023 | 36672991 | PubTator, text mining | PubMed |
| Role of circulating exosomal biomarkers and their diagnostic accuracy in pancreatic cancer. | JGH Open | 2023 | 36660044 | PubTator, text mining | PubMed |
| Supratentorial tumor resembling anaplastic ependymoma in an adolescent. | Brain Pathol | 2023 | 36656730 | PubTator, text mining | PubMed |
| A knockout-first model of H3f3a gene targeting leads to developmental lethality. | Genesis | 2023 | 36656301 | PubTator, text mining | PubMed |
| Impact of epigenetic reprogramming on antitumor immune responses in glioma. | J Clin Invest | 2023 | 36647827 | PubTator, text mining | PubMed |
| Diagnostic and therapeutic challenges of glioblastoma as an initial malignancy of constitutional mismatch repair deficiency (CMMRD): two case reports and a literature review. | BMC Med Genomics | 2023 | 36647049 | PubTator, text mining | PubMed |
| Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series. | Sci Rep | 2023 | 36646712 | PubTator, text mining | PubMed |
| Events in CNS Tumor Pathology Post-2016 WHO CNS: cIMPACT-NOW Updates and Other Advancements: A Comprehensive Review Plus a Summary of the Salient Features of 2021 WHO CNS 5. | Int J Gen Med | 2023 | 36644568 | PubTator, text mining | PubMed |
| The U2AF65/circNCAPG/RREB1 feedback loop promotes malignant phenotypes of glioma stem cells through activating the TGF-β pathway. | Cell Death Dis | 2023 | 36635261 | PubTator, text mining | PubMed |
| Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes. | J Clin Invest | 2023 | 36633903 | PubTator, text mining | PubMed |
| Diagnostic value of H3F3A mutation and clinicopathological features of giant cell tumours in non-long bones. | J Bone Oncol | 2023 | 36619849 | PubTator, text mining | PubMed |
| The clinicopathological features and prognosis of multifocal high-grade gliomas in adults with H3F3A mutation. | Neurosciences (Riyadh) | 2023 | 36617452 | PubTator, text mining | PubMed |
| Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors. | Pediatr Neurosurg | 2023 | 36617415 | PubTator, text mining | PubMed |
| Clinical characteristics and prognosis of Glioblastoma patients with infratentorial recurrence. | BMC Neurol | 2023 | 36609238 | PubTator, text mining | PubMed |
| Imaging characterization of an adult H3 K27M-altered diffuse midline glioma of the medulla oblongata with a confounding steroid response. | Radiol Case Rep | 2023 | 36589504 | PubTator, text mining | PubMed |
| Utility of arterial spin labeling for objective assessment of intratumoral microvessels in diffuse hemispheric glioma, H3 G34R-mutant: A case report and literature review. | Radiol Case Rep | 2023 | 36589502 | PubTator, text mining | PubMed |
| Histone variant H3.3 promotes metastasis in alveolar rhabdomyosarcoma. | J Pathol | 2023 | 36573560 | PubTator, text mining | PubMed |
| Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients. | Pediatr Blood Cancer | 2023 | 36573296 | PubTator, text mining | PubMed |
| Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants. | Neuro Oncol | 2023 | 36541551 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3020/papers?page=19